Background-Atrial fibrillation impairs atrial contractility, inducing atrial stunning that promotes thromboembolic stroke.
] i transients and cell shortening of control cardiomyocytes; whereas control AP waveforms improved [Ca 2ϩ ] i transients and cell shortening in ATR cells. However, ATR cardiomyocytes clamped with the same control AP waveform had Ϸ60% smaller [Ca 2ϩ ] i transients and cell shortening than control cells. We therefore sought additional mechanisms of contractile impairment. Whole-cell voltage clamp revealed reduced I CaL ; I CaL inhibition superimposed on ATR APs further suppressed [Ca 2ϩ ] i transients in control cells. Confocal microscopy indicated ATR-impaired propagation of the Ca 2ϩ release signal to the cell center in association with loss of t-tubular structures. Myofilament function studies in skinned permeabilized cardiomyocytes showed altered Ca 2ϩ sensitivity and force redevelopment in ATR, possibly due to hypophosphorylation of myosin-binding protein C and myosin light-chain protein 2a (immunoblot). Hypophosphorylation was related to multiple phosphorylation system abnormalities where protein kinase A regulatory subunits were downregulated, whereas autophosphorylation and expression of Ca 2ϩ -calmodulin-dependent protein kinase II␦ and protein phosphatase 1 activity were enhanced. Recovery of [Ca 2ϩ prolonging drugs improve ATR-induced atrial hypocontractility. 3 APD is an important determinant of cellular Ca 2ϩ loading and the systolic Ca 2ϩ transient that triggers contraction. ATR decreases atrial cardiomyocyte Ca 2ϩ transients, contributing to impaired cellular contractile function. 2 Reduced Ca 2ϩ transients have been related to decreased cellular Ca 2ϩ entry resulting from L-type Ca 2ϩ current (I CaL ) downregulation by ATR, 2, 4 but the marked APD shortening caused by ATR could itself account for reduced Ca 2ϩ transients and hypocontractility. 3, 5 Ca 2ϩ -handling protein phosphorylation changes also occur in AF. 6 A recent study reported subcellular Ca 2ϩ -handling abnormalities in atrial hypocontractility caused by chronic (over several months) AF. 7 However, short-term AF (over several days) can cause reversible atrial mechanical dysfunction and thromboembolic complications, 8 with apparent normalization by APD-prolonging drugs. 3 This study aimed to (1) evaluate the role of APD changes in hypocontractility induced by 1-week ATR, (2) determine whether APD changes alone were insufficient to account for contraction abnormalities, and (3) assess in detail other potential contributors.
Methods
This section includes essential methodologies. Additional details are found in the online-only Data Supplement.
Animal Model
All animal care and handling procedures were in accordance with National Institutes of Health guidelines (http://oacu.od.nih.gov/ training/index.htm) and were reviewed and approved by the Animals Research Ethics Committee of The Montreal Heart Institute (Montréal, Quebec). Sixty-three adult mongrel dogs (22 to 36 kg) were divided into 2 groups: control (nϭ35) and 1-week ATR (nϭ28). Under diazepam (0.25 mg/kg IV), ketamine (5.0 mg/kg IV), and halothane (1% to 2%) anesthesia, unipolar leads were inserted into the right ventricular apex and right atrial (RA) appendage and connected to pacemakers in the neck. Atrioventricular block was created by radiofrequency ablation, and the right ventricle pacemaker was programmed to 80 bpm. After 24-hour recovery, the atrial pacemaker was programmed to pace the RA appendage at 400 bpm for 7 days.
On study days, dogs were anesthetized with morphine (2 mg/kg SC) and ␣-chloralose (120 mg/kg IV load at 29.25 mg/kg per hour) and ventilated mechanically. RA appendage effective refractory periods (AERPs) were determined with 8 basic stimuli followed by 1 premature stimulus (5-millisecond [ms] decrements). AF was induced multiple times by burst pacing to determine AF duration in each dog, and mean AF duration was calculated using average individual dog AF duration values.
Transthoracic echocardiography was performed under sedation (acepromazine 0.07 mg/kg and buprenorphine 0.009 mg/kg IM) in sinus rhythm. An average of 3 to 6 cardiac cycles was used, with the operator blinded to treatment assignment.
After open chest studies, hearts were excised through a median thoracotomy and immersed in oxygenated Tyrode solution. RA tissue was frozen in liquid N 2 for molecular biology. For cellular studies, RA preparations were coronary perfused at Ϸ10 mL/min for cardiomyocyte isolation. After perfusion with Ca 2ϩ -free Tyrodecontaining collagenase (110 U/mL) and 0.1% bovine serum albumin for Ϸ40 minutes, single cells were obtained by trituration. Cell capacitance averaged 102Ϯ4 picofarads and 101Ϯ5 picofarads in control and ATR cells, respectively.
Cellular Studies
Isolated cardiomyocytes were field stimulated through 10-ms 1.5ϫthreshold square-wave pulses at a temperature of 35°C. Cell shortening, maximum contracting (ϩ⌬L/⌬t), and relaxing (Ϫ⌬L/⌬t) slopes of cell shortening were measured by video edge detection based on the average of 10 consecutive beats. Cell shortening was measured during field stimulation with a video edge detector, with edge detection cursors positioned at both cell ends to measure whole-cell shortening. When AP clamp waveforms were applied through a patch pipette, absolute cell shortening was measured at only 1 cell end. AP recordings were performed with whole-cell perforated patch techniques and current-clamp mode. Pipette tips were filled with nystatin-free intracellular solution by capillary action, and pipettes then were back filled with nystatin-containing (600 g/mL) pipette solution. Whole-cell voltage clamp was performed with tight seal methods. Tip resistances were between 3 and 5 M⍀. Junction potentials averaged 15.9 mV and were corrected for AP recordings only. All recordings were performed at 35Ϯ0.5°C. In some experiments, mean control or ATR AP waveforms were applied as voltage-clamp command signals while recording Ca 2ϩ transients or cell shortening. RA cardiomyocytes were subjected to typical AP waveforms from control and ATR cardiomyocytes at 2 Hz for sequential 6-minute periods (in randomized order). Parallel Ca 2ϩ transients (10 to 20 beats) were recorded in 120-second intervals. For analysis, all Ca 2ϩ transients obtained during the 6-minute periods were averaged and the meanϮSEM calculated within each AP waveform group. For solution contents, see the online supplement.
Transverse Tubule Network Analysis
Freshly isolated atrial cells were plated on laminin-coated Petri dishes. Cells were labeled with 2-mol/L di-4-ANEPPS in Tyrode solution. Samples were excited with an argon (488-nm) laser, and emitted fluorescence over 515-nm Z-series (250 nm) was acquired with an LSM 710 confocal microscope. The calculated point spread function of the imaging system was obtained with the use of 170-nm fluorescent latex beads. Acquired Z-series were deconvolved using maximum likelihood estimation with a Richardson-Lucy algorithm following gaussian prefiltering implemented with Huygens Professional 3.5.0. Projections were analyzed by excluding the cell membrane and quantifying intracellular membrane staining. Transverse tubule (t-tubule) density was estimated from the pixel intensity normalized to the surface area of the intracellular region for each cardiomyocyte.
Skinned Cardiomyocyte Studies
Cardiomyocytes were mechanically isolated, permeabilized, and mounted. Isometric force measurements were performed at 15°C and resting sarcomere length of 2.2 m. Force redevelopment rate (K TR ) was determined during activation at different Ca 2ϩ concentrations. Force redevelopment after restretch was fitted by a single exponential function (Marquart-Levenberg algorithm) to estimate K TR . Passive force was determined in relaxing solution by applying the same shortening (20% of original cell length) followed by a restretch after 10 seconds.
Protein Studies
RA tissue homogenates were prepared from freeze-dried tissue, and protein concentrations were determined with Amido-black 10B. Proteins were fractionated on SDS-PAGE and transferred to nitrocellulose membranes. Protein expression was quantified as previously described. 6 For details regarding antibodies, dilution, and source, see the online supplement. Serine and threonine protein phosphatase activity were assessed with phosphorylase-A as substrate and quantified as nanomoles of 32 P i released/mg protein per minute. Differentiation between type 1 and type 2A protein phosphatase (PP1 and PP2A, respectively) activities was obtained with okadaic acid (3 nmol/L). Protein bands were visualized with electrochemoluminescence reagents and Hyperfilm-ECL. The films were evaluated densitometrically with Phoretix 1D software. Myosin heavy chain (MHC) isoform composition was analyzed by 1D SDS-PAGE. The separating gel contained 12% total acrylamide (acrylamide-to-bis-acrylamide ratio, 200:1; pH 9.3), whereas the stacking gel contained 3.5% total acrylamide (acrylamide-to-bis-acrylamide ratio, 20:1; pH 6.8). Gels were silver stained and analyzed by laser densitometry. To check for linearity, different amounts of protein were loaded on the gels, and band densities were determined. Only samples within the linear range (typically 0.2 to 1.0 g of total protein) were used in the evaluation. Agarose-strengthened 2% SDS-PAGE was used to detect titin. All data are presented as meanϮSEM. For single comparisons, paired or nonpaired t tests were applied as appropriate. Repeatedmeasures analyses were performed with 2-way ANOVA. When significant interactions were found between main effects, Bonferroni-corrected t tests were applied to determine the levels of the repeated measures at which significant differences occurred (the P values shown were obtained by multiplying each P by the number of repeated tests performed). In the absence of interaction, the significance of main effects differences is shown. Analyses of nonrepeated measurements in multiple groups (control versus 24-hour recovery versus 48-hour recovery) were performed by 1-way ANOVA followed (if significant) by the least significant difference test. The specific statistical test applied for each analysis is provided in the online supplement. A 2-tailed PϽ0.05 was considered statistically significant.
Data Analysis
The authors had full access to the data and take responsibility for its integrity. All authors have read and agree to the manuscript as written.
Results

In Vivo Experiments
All ATR dogs showed atrial remodeling, with significantly reduced AERPs and AERP rate adaptation (Table 1) . Arterial pressures, left ventricular (LV) end-diastolic pressure, and RA pressure were unchanged by ATR. ATR significantly increased the duration of burst pacing-induced AF, an index of the AF-maintaining substrate, by Ϸ10-fold (PϽ0.001). Echocardiography revealed atrial contractile dysfunction in ATR ( Figure 1A and B). Overall, atrial fractional area and diameter shortening were decreased by Ϸ14% (PϽ0.05) and Ϸ26% (PϽ0.05), respectively ( Figure 1C ). Mitral valve A-wave velocity (representing active atrial contractile function) was decreased by Ϸ45% in ATR (PϽ0.05) ( Figure 1D ), whereas E-wave velocity (representing passive atrial emptying function) was unchanged. The E/A ratio was nearly doubled by ATR (2.7Ϯ0.2) versus control (1.6Ϯ0.2; PϽ0.05) ( Figure 1E ). LV dimensions and ejection fraction were unchanged ( Table 2) .
Cell Shortening, Ca 2؉ Transients, and APD Figure 2A shows representative cell shortening recordings at 1 Hz. Overall cell shortening was strongly reduced by Ϸ85% (PϽ0.001) in ATR cardiomyocytes versus control cells ( Figure 2B ). ATR decreased cell shortening over a wide range of frequencies (PϽ0.001) (supplemental Figure 1 ). Absolute cell shortening and relaxation rates were substantially reduced in ATR (ϩ⌬L/⌬t and Ϫ⌬L/⌬t by 81% and 93%, respectively; PϽ0.001 for each) ( Figure 2C ). Figure 3C ). These results point to reduced SR-derived Ca 2ϩ transients associated with reduced SR Ca 2ϩ stores as a basis for hypocontractility, consistent with prior observations. 2 We then recorded AP waveforms. Ca 2ϩ entry occurs predominantly during the AP plateau where changed plateau voltages and durations affect SR Ca 2ϩ loading 9 and could explain ATR-induced hypocontractility. 3 Figure 3D shows representative AP recordings. ATR abbreviated APD over a wide range of frequencies by Ϸ50% overall (PϽ0.001) ( Figure 3E ). Figure 4B ). We then used the same approach to study the impact of APD abbreviation on cell shortening in AP-clamped control cells. The ATR AP waveform also substantially reduced cell shortening ( Figure 4C , left) by Ϸ75% overall (PϽ0.001) ( Figure 4C, right) .
Contribution of AP Waveform Changes to
If the AP waveform changes induced by ATR are the sole cause of cell Ca 2ϩ and contractile abnormalities, it should be possible to normalize Ca 2ϩ transients and cell shortening by applying control waveforms to ATR cells. Ca 2ϩ transient recordings from an ATR cell exposed to control and ATR waveforms are shown in Figure 4D . The control AP waveform improved the Ca 2ϩ transient; overall, Ca 2ϩ transient amplitudes were approximately doubled (PϽ0.05) in ATR cells when control waveforms were applied ( Figure 4E ). Nevertheless, comparing the recordings in Figure 4D with control cell recordings in Figure 4A and mean data in Figure   Figure 2 4E with control cell data in Figure 4B , the control AP waveform did not normalize Ca 2ϩ transients in ATR cells. 
I CaL Changes
Previous studies have shown important I CaL downregulation in ATR, 4, 10, 11 and I CaL is the major source of Ca 2ϩ entry for SR Ca 2ϩ loading. 9 For a given AP waveform, decreased I CaL channel function would be expected to diminish cellular Ca Figure 4A shows representative I CaL recordings, and Figure 4B shows corresponding current density-voltage relations. Overall, peak I CaL density was reduced by 63% in ATR cells (PϽ0.001 at all test potentials between Ϫ10 and ϩ40 mV). In contrast to findings with EGTA-containing pipettes, fast inactivation time constants were significantly slowed (PϽ0.001) (supplemental Figure 5A ), consistent with reduced Ca 2ϩ -dependent I CaL inactivation. Slow I CaL inactivation kinetics (supplemental Figure 5B ) and I CaL voltage dependence (supplemental Figure 5C ) were unaltered by ATR under EGTA-free conditions, but recovery was accelerated (PϽ0.01) (supplemental Figure 5D) .
To assess whether decreased Ca 2ϩ entry through I CaL reduces Ca 2ϩ transients over and above the APD abbreviation caused by ATR, we recorded Ca 2ϩ transients in control cells subjected to AP clamping with control APs, ATR APs, and then ATR APs in the presence of 5 mol/L nifedipine. Figure  5A shows 
Expression and Phosphorylation of Key Ca
2؉ -Handling Proteins
To uncover potential contributions of altered Ca 2ϩ -handling protein expression to Ca 2ϩ -handling abnormalities, we performed Western blots with specific antibodies directed against total and phosphorylated forms of target proteins. We found no significant differences between ATR and control atria in SR-associated proteins (supplemental Figure 6 ). Expression levels of total ryanodine receptor 2 (RyR2), protein kinase A (PKA)-phosphorylated RyR2 (at Ser2809), Ca 2ϩ -calmodulin-activated protein kinase (CaMKII)-phosphorylated RyR2 (at Ser2815), and fractional RyR2-phosphorylation states (ratios of Ser2809-RyR2 and Ser2815-RyR2 to total RyR2) were similar in control and ATR cells (supplemental Figure 6A) . Calsequestrin-2, the major SR Ca 2ϩ buffer system protein, was similarly unaffected by ATR, as were SR Ca 2ϩ ATPase and Na ϩ ,Ca 2ϩ exchange 1 (supplemental Figure 6B) . No significant changes were noted for total phospholamban (PLB) or for PKA-phosphorylated (at Ser16) or CaMKII-phosphorylated (at Thr17) PLB.
Subcellular Ca 2؉ Handling
Recent studies have emphasized the importance of subcellular Ca 2ϩ -handling abnormalities in rabbits with ATR 12 and sheep with long-standing AF or heart failure. 7, 13 We assessed this possibility in control and ATR cardiomyocytes with the use of confocal microscopy. Longitudinal line scans showed no significant change in cells from ATR dogs compared with controls (supplemental Figure 7) . propagation toward the center of the cell ( Figure 6B ). Confocal imaging with di-4-ANEPPS indicated the presence of t-tubular structures under control conditions, which were greatly reduced in ATR cells (supplemental Figure 8A) . Overall, t-tubule density was decreased by Ϸ60% in ATR (PϽ0.01) (supplemental Figure 8B ).
Force Development in Permeabilized Cardiomyocytes
To investigate whether abnormal myofibrillar behavior may contribute to atrial contractile dysfunction, we assessed myofilament mechanics by recording force development in skinned permeabilized cardiomyocytes ( Figure 7A ). Passive and active force development and K TR were measured in 18 cardiomyocytes from 5 ATR dogs and 19 cardiomyocytes from 5 control dogs. Figure 7B shows a recording of isometric force development in an ATR cardiomyocyte at saturating Ca 2ϩ (pCa 4.5). Overall data are presented in Figure 7C . Figure 7D, right) .
Expression and Phosphorylation of Key Myofilament Proteins
We analyzed expression changes in important myofilament proteins as a potential contributor to contractile abnormalities. Expression levels of thin myofilament proteins troponin (Tn)I and TnC are shown in Figure 8A . Total TnI expression, PKA-phosphorylated (at Ser23/24) TnI, the phosphorylated/ total TnI ratio, and total TnC were unchanged by ATR. Thick myofilament and myosin-related protein results are presented in Figure 8B . Total protein levels of thick myofilament myosin-binding protein-C (MyBP-C) were unchanged. However, PKA-phosphorylated MyBP-C (at Ser282) was significantly decreased in ATR by Ϸ35% (PϽ0.05), resulting in a decreased Ser282-MyBP-C/total MyBP-C ratio (PϽ0.05). Reduced MyBP-C phosphorylation could contribute to alterations in cross-bridge kinetics. Myosin light chain (MLC) kinase phosphorylation of MLC protein-2a (MLC2a) at Ser21/22 is suggested to improve atrial contractility by improving cross-bridge cycling kinetics, 14 and we found a Ϸ30% reduction in MLC2a phosphorylation in ATR (PϽ0.05) ( Figure 8B ). Contractile protein composition was determined by 1D SDS-PAGE (supplemental Figure 9) . The detail of the MHC region shown in Figure 8C illustrates the presence of 2 MHC-isoforms, fast (␣) and slow (␤), in atrial tissue. The quantity of ␣-MHC as a percentage of total (␣ϩ␤) MHC content was not affected by ATR. The expression of titin, a giant protein that acts as a molecular spring in the I-band, is anchored at the Z-disk, and is expressed in 2 main cardiac isoforms (a longer, more-compliant N2BA titin [3.3 to 3.5 MDa] and a shorter, stiffer N2B titin [3.0 MDa]) was unchanged in ATR ( Figure 8D) . Overall, the myofilament analyses point to dephosphorylation of MyBP-C and MLC2a as potential contributors to ATR-induced myofilament dysfunction.
Phosphorylation Changes, Kinases, and Phosphatases
To identify potential sources of altered myofilament protein phosphorylation, we analyzed the expression of PP1 and PP2A and of PKA and CaMKII (supplemental Figure 10) . In addition, we directly measured PP enzyme activity. Total (PP1ϩPP2A) and PP2A-related activities were comparable in both groups, whereas PP1 activity was 28% greater in ATR (PϽ0.05) (supplemental Figure 10A) . The increased PP1 activity was not attributable to expression differences (supplemental Figure 10B ). PKA expression was unchanged for PKAc (the catalytic subunit), whereas the regulatory subunit PKA II␣ was decreased by 33% (PϽ0.05) (supplemental Figure 10C) . ATR increased the expression and autophosphorylation of the cytosolic CaMKII␦ isoform by 78% and 123%, respectively (PϽ0.05 for each), whereas the ratio of autophosphorylated CaMKII␦ to total CaMKII␦ was unchanged (PϭNS) ( Figure 8D ). The increase in PP1 activity and decrease in PKA II␣ protein expression, consistent with previous data, 6, 15 potentially account for the observed myofilament protein dephosphorylation. Increased PP1 activity may have offset the increased expression of the cytosolic CaMKII␦ isoform, explaining the lack of changes in CaMKII phosphorylation of investigated proteins.
Recovery of ATR-Induced Electrophysiological and Contractile Alterations
To analyze the relationship between electric and contractile changes during ATR recovery, we studied dogs (5 per group) subjected to 7-day ATR followed by a 24-or 48-hour nonpaced recovery interval as well as 5 concurrent controls. The results are summarized in Table 3 . After 24-hour recovery, significant decreases remained for APDs recorded over a wide range of frequencies (PϽ0.01) (supplemental Figure  11A) , Ca 2ϩ transients (PϽ0.01) (supplemental Figure 11B) , and cell-shortening (PϽ0.001) (supplemental Figure 11C) . In contrast, full recovery was seen for all indices at 48 hours (PϭNS versus control).
Discussion
In the present study, we observed that 7 days of ATR are sufficient to substantially impair atrial contractile function. A significant part of the contractile abnormality can be attributed to AP changes caused by ATR, but even when these are accounted for, substantial abnormalities in atrial Ca 2ϩ release and contractility remain. Detailed analyses point to loss of I CaL as a significant additional contributor along with potential roles for disturbed subcellular distribution of Ca 2ϩ release and intrinsic myofilament dysfunction likely caused by myosin and myosin-associated protein dephosphorylation.
Previous Studies of Atrial Hypocontractility Mechanisms
It has long been recognized that AF causes atrial hypocontractility, 16 and the role of atrial contractile dysfunction in the thromboembolic complications of AF is well appreciated. 8 Even very short-term AF (5 to 15 minutes) can cause contractile dysfunction, but normal contraction resumes within minutes of rhythm reversion after such brief episodes, whereas persistent hypocontractility (lasting Ն24 hours) follows AF episodes lasting days to weeks. 8 Atrial tachypaced dogs with uncontrolled ventricular responses show an atrial cardiomyopathic phenotype, with contractile dysfunction related to reduced Ca 2ϩ transients of uncharacterized mechanism. 2 In atrial tissue samples from patients with AF, contractile force is impaired and can be normalized by increasing extracellular Ca 2ϩ but not by exposure to a Ca 2ϩ channel agonist, again suggesting a primary role for reduced Ca 2ϩ load. 5 Several recent studies have addressed the mechanisms of Ca 2ϩ transient abnormalities associated with atrial pathology. Lenaerts et al 7 reported detailed studies in sheep with longstanding AF (average Ͼ4 months) and ventricular dysfunction. Like us, they observed striking APD abbreviations and reduced Ca 2ϩ transients. I CaL was diminished, but the reduction was limited when EGTA was omitted from the pipette. They also noted increased Na ϩ , Ca 2ϩ exchange function and expression and emphasized the importance of reduced subsarcolemmal-RyR coupling efficiency along with loss of t-tubules. They did not examine the role of APD changes or Figure 8 . Protein expression data (meanϮSEM band intensities normalized to GAPDH and expressed relative to CTL) and corresponding illustrative examples (right). A, TnI, Ser23/24 TnI-P, and TnC with corresponding GAPDH bands (CTL, nϭ10; ATR, nϭ8 atria/analysis). B, Total MyBP-C, Ser282 MyBP-C-P, and PKA MLC2a-P with corresponding GAPDH bands (CTL, nϭ14; ATR, nϭ10 atria/analysis). *PϽ0.05 versus CTL. C, MHC isoform composition (meanϮSEM values for ␣ MHC expression as a percentage of total (␣ϩ␤) MHC expression) and detail of the MHC region of an SDS-PAGE illustrating the similarity in MHC expression in the 2 groups (right). D, Titin N2BA and N2B isoforms separated by 2% SDS-PAGE (N2BA:N2B ratio meanϮSEM; nϭ10 atria/group per analysis; PϭNS ATR versus CTL). CTL indicates control; MLC2a-P, phosphorylated MLC2a; MyBP-C-P, phosphorylated MyBP-C; T2, titin degradation band; TnI-P, phosphorylated TnI. intrinsic contractile properties. Dibb et al 13 characterized Ca 2ϩ release properties in sheep with ventricular tachypacing-induced heart failure. They noted substantial loss of t-tubules associated with impaired centripetal propagation of the Ca 2ϩ signal from the subsarcolemma to the center of the cell. However, in rabbit atrial myocytes, ATR suppresses centripetal Ca 2ϩ wave propagation despite a lack of t-tubules, pointing to mechanisms other than reduced t-tubular density. 12 Several studies have suggested a prime role of atrial APD abbreviation in AF-related contractile dysfunction. Atrial contractility decreases rapidly in goats with electrically maintained AF, with a similar time-course to AERP abbreviation. 17 Administration of the K ϩ channel blocker AVE0118 increases AERP and atrial contractility in contrast to absent or limited effects of other positive inotropic agents like digoxin, dobutamine, the Ca 2ϩ sensitizer EMD57033, and the Ca 2ϩ channel agonist BayY5959. 3 Similar effects of AVE0118 have been observed in RA trabeculae of patients with AF. 18 On the basis of this evidence, the use of APDprolonging agents has been advocated to abrogate atrial hypocontractility in AF. 3 MyBP-C dephosphorylation has been noted in atrial tissue samples from patients with AF. 6 No previous studies have noted changes in the expression and phosphorylation of MLC2a, an important regulator of cardiac contraction. 19 Eiras et al 20 described decreased force redevelopment in skinned muscle fibers from patients with dilated atria in both sinus rhythm and AF along with increased expression of ␤ MHC protein, TnT, and desmin in patients with AF only. Most patients with AF had significant valvular heart disease (unlike the control, sinus rhythm, and dilated atria groups), which can markedly alter atrial function and gene expression. 21 We noted changes in contractile protein (MyBP-C and MLC2a) phosphorylation that likely contributed to contractile abnormalities and addressed potential underlying mechanisms by studying changes in key phosphorylation (kinase) and dephosphorylation (phosphatase) systems. Consistent with previous data in patients with chronic AF and goats with sustained AF, 6,15 global PP1 activity was increased in ATR, whereas protein expression of the regulatory PKAII␣ subunit (which coordinates targeting of the PKAc subunits to PKA targets) was reduced. Although we did not directly measure PP1 and PKA activities in the myofilament and SR compartments, greater local PP1, reduced PKA, or both activity likely underlies hypophosphorylation (and resulting dysfunction) of the 2 key cross-bridge cycling regulatory proteins MyBP-C and MLC2a at established PKA sites. PKA phosphorylation of RyR2 and PLB (Ser2809 and Ser16 sites, respectively) was preserved in ATR despite increased PP1 activity and reduced PKAII␣ expression. In patients with chronic AF, SR-related PP1 function is reduced because of increased inhibitor 1 activity, 6 which controls PP1 activity exclusively at the SR, specifically targeting phosphorylation of PLB and RyR2 at Ser16 and Ser2815 sites, respectively. 22, 23 Thus, reduced PP1 activity in the SR compartment of ATR dogs may offset reductions in PKAII␣ expression at Ser16. On the other hand, although higher global activity of CaMKII in the face of reduced SR-related PP1 activity in ATR would be expected to increase phosphorylation at CaMKII phosphorylation sites of RyR2 and PLB (Ser2815 and Thr17, respectively), steadystate phosphorylation at these sites was unchanged. Further work clearly is needed to explain more fully SR PKA and CaMKII phosphorylation properties in ATR.
Novel Elements and Potential Significance
Atrial contractile remodeling has important clinical consequences, including increased atrial thrombogenesis and stroke risk in patients with AF. 24 -26 Elucidating the underlying pathophysiological mechanisms may allow for the identification of new therapeutic targets. Whereas atrial contractility changes have been attributed previously to APD reduction based on indirect evidence, 3, 15, 17, 18 our study is the first to our knowledge to examine directly the role of ATR-induced AP waveform alterations. By applying AP waveforms from control and ATR cardiomyocytes to cells from both types of dogs ( Figure 4) we were able to conclude that ATR-induced AP changes do contribute significantly to Ca 2ϩ release and contractile disturbances but that APD alterations account for only a minority of the abnormalities observed. We identified a range of additional contributors, indicating that the contractile dysfunction caused by ATR is multifactorial and implying that the targeting of any single pathophysiological component is unlikely to be successful. Indeed, despite the fact that the repolarization-prolonging agent AVE0118 was the most effective single intervention in restoring atrial contractility in AF remodeled goats, 3 atrial shortening velocity abnormalities were incompletely reversed (by 65% in RA and 75% in left atrium), whereas AERP was increased to 120% of pre-AF values.
ATR can cause APD abbreviation by several ionic mechanisms, including I CaL reduction and increased inward rectifier currents. 21, 27 The present study is the first to address the specific role of I CaL reduction, independent of associated APD decreases, in ATR-induced Ca 2ϩ release and contractile impairments. Our results indicate that I CaL decreases produce disproportionate impairments by virtue of their combined effects on APD and Ca 2ϩ entry through I CaL channels. Previous experimental studies of ATR AF-related contractile dysfunction have used animals with uncontrolled ventricular responses, 2, 3, 7, 15 resulting in varying degrees of ventricular dysfunction known to importantly alter atrial cardiomyocyte subcellular properties and Ca 2ϩ handling. 13 Here, we show that relatively short-term (7-day) ATR itself, with a controlled ventricular response and unaltered ventricular function (Table 2) , significantly depresses atrial contractility through a variety of cellular and subcellular mechanisms.
Potential Limitations
We chose a 1-week period of ATR based on the fact that ion current changes caused by ATR reach near steady-state after 1 week. 4 Shapiro et al 28 showed that patients with acute AF (mean duration, 1.8 days) do not show significant postcardioversion atrial dysfunction, whereas AF lasting longer than 1 week causes substantial atrial contractile abnormalities that require several days to recover. ATR lasting for considerably longer periods could produce further changes in contractility involving additional mechanisms where the existence of slowly developing components to AF remodeling is well recognized. 29, 30 Nevertheless, the contractility changes that we observed are quite similar to those noted by Lenaerts et al 7 after a mean 129-day AF period in sheep.
Our studies indicate that a variety of mechanisms likely contribute to ATR-induced Ca 2ϩ release and contractile abnormalities, which is somewhat unsatisfying because the precise contribution of each individual component is difficult to assess and may vary with the duration of ATR, presence of associated heart disease, drug therapy, and so forth. As unappealing as this biological reality is, it is important to appreciate that the variety of mechanisms contributing to atrial contractile dysfunction after as few as 7 days of ATR suggests that therapies targeting common upstream signaling events or rapid atrial activation itself may be more effective than attempting to intervene at the level of specific downstream pathophysiological contributors to hypocontractility.
